You are here: Industry Insights > Clinical Trial

News List

China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL prnasia
January 14, 2021
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted approval for a pivotal seamless Phase 1/2 clinical ...
Dr Reddy’s announces Sputnik V meets primary endpoint of safety in Phase 2 trial in India expresspharma
January 13, 2021
Dr Reddy’s submitted the phase 2 safety data for DCGI’s approval to continue phase 3 clinical trials.
Ampio Provides Update on Clinical Trials for COVID-19 Treatment americanpharmaceuticalreview
January 12, 2021
Ampio Pharmaceuticals announced an update on the launch of a new global clinical trial for intravenous (IV) treatment of COVID-19 with Ampion and provided updates on its ongoing U.S. trial for inhalation treatment of COVID-19.
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients prnasia
January 11, 2021
Kintor Pharmaceutical Limited is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients.
AM-Pharma enrols first Covid-19 patients in Phase III clinical trial pharmaceutical-technology
January 11, 2021
AM-Pharma has announced the enrolment of first participants in an exploratory cohort in Phase III REVIVAL pivotal trial of its human recombinant alkaline phosphatase (AP) for treating patients with Covid-19 and sepsis-associated acute kidney injury.
Bharat Biotech to start Phase-1 trials of intranasal COVID-19 vaccine in Feb-March 2021 expresspharma
January 11, 2021
The company is developing this a single dose intranasal vaccine for COVID-19 in partnership with Washington University School of Medicine in St Louis.
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China prnasia
January 08, 2021
VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world's leading treatment methods and drugs into the China market and hoping to provide more Chinese patients quick access to the ...
The Health Research Authority launches fast-track service for non-COVID-19 research pharmatimes
January 08, 2021
The Health Research Authority (HRA) has launched a new service offered to pharmaceutical companies and research organisations which will accelerate the ethics review stage of clinical trials approval.
Parexel Appoints Chief Patient Officer contractpharma
January 07, 2021
Parexel, a provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, has appointed Clare Grace, Ph.D., as the company’s first chief patient officer.
India gives restricted emergency use approval for two Covid-19 vaccines pharmaceutical-business-review
January 06, 2021
India's Central Drugs Standard Control Organisation (CDSCO) has given the restricted emergency use approval for Covid-19 vaccines of Serum Institute of India and Bharat Biotech.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page